EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence in contrast-enhanced mammography: Current evidence, clinical integration, and future perspectives – a narrative review

Graziella Di Grezia, Teresa Iannaccone, Antonio Nazzaro, Leandra Piscopo, Salvatore Antonio Masala, Mariano Scaglione

Eurasian Journal of Medicine and Oncology · 09.09.2026 · 10 (5) · 026250294

DOI: 10.36922/ejmo026250294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 09.09.2026. Verfasst von Graziella Di Grezia und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Contrast enhanced mammography (CEM) combines standard mammographic imaging with functional enhancement patterns and is increasingly used in diagnostic and staging pathways. Artificial intelligence (AI) has shown strong potential in breast imaging, yet its application to CEM remains limited.

Objectives

This narrative expert review summarizes current evidence on AI applied to CEM, identifies methodological gaps, and outlines future directions for clinically integrated, precision-oriented models.

Methods

A narrative review of peer‑reviewed studies was conducted, focusing on AI for lesion detection, classification, segmentation, radiomics, workflow support, and emerging multidimensional frameworks involving CEM. Given the heterogeneity of available studies and the early developmental stage of the field, a narrative expert review was considered more appropriate than a protocol‑driven systematic approach.

Results

Existing studies demonstrate that AI can improve lesion conspicuity, support automated detection, and extract quantitative features from CEM. Reported performance metrics—such as area‑under‑the‑curve (AUC) values between 0.87 and 0.93 in small datasets—indicate promising diagnostic potential. However, progress is limited by small sample sizes, heterogeneous acquisition protocols, variability in background parenchymal enhancement, lack of external validation, and the absence of models incorporating clinical, hormonal, or multimodal information essential for real‑world interpretation. Emerging frameworks suggest that AI may also support multidimensional risk profiling by integrating imaging features with patient‑specific variables.

Conclusions

AI has the potential to enhance the diagnostic and clinical value of CEM, but meaningful implementation will require standardized acquisition, larger multicenter datasets, explainable architectures, and integration of clinical context. Future models should reflect real-world senological workflows and support personalized, risk‑stratified decision‑making.

Zitieren

APA

Grezia, G. D., Iannaccone, T., Nazzaro, A., Piscopo, L., Masala, S. A., & Scaglione, M. (2026). Artificial intelligence in contrast-enhanced mammography: Current evidence, clinical integration, and future perspectives – a narrative review. Eurasian Journal of Medicine and Oncology, 10(5), 026250294. https://doi.org/10.36922/ejmo026250294

Vancouver

Grezia GD, Iannaccone T, Nazzaro A, Piscopo L, Masala SA, Scaglione M. Artificial intelligence in contrast-enhanced mammography: Current evidence, clinical integration, and future perspectives – a narrative review. Eurasian Journal of Medicine and Oncology. 2026;10(5):026250294. doi:10.36922/ejmo026250294

BibTeX
@article{Grezia2026,
  author = {Grezia, Graziella Di and Iannaccone, Teresa and Nazzaro, Antonio and Piscopo, Leandra and Masala, Salvatore Antonio and Scaglione, Mariano},
  title = {Artificial intelligence in contrast-enhanced mammography: Current evidence, clinical integration, and future perspectives – a narrative review},
  journal = {Eurasian Journal of Medicine and Oncology},
  year = {2026},
  volume = {10},
  number = {5},
  pages = {026250294},
  doi = {10.36922/ejmo026250294}
}
Kostenlos starten →